| Name | Title | Contact Details |
|---|
Biomedical International is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sarah Bush Lincoln Health Center is a 129-bed, not-for-profit, regional hospital centrally located in East Central Illinois Coles County, and is the recipient of the 2011 Illinois Performance Excellence Gold Award for Achievement of Excellence, the highest performance honors in the state. Sarah Bush Lincoln is accredited by The Joint Commission, the nations oldest and largest standards-setting and accrediting body in healthcare. The Health Center provides a full range of acute care services to residents of Coles County and the surrounding eight counties. Home health services extend to the surroundings 19 counties in East Central and Southern Illinois. Active and consulting medical staffs include approximately 175 providers representing 28 specialties. Some of the services provided by the Health Center include: a Regional Cancer Center, a Heart Center with Cardiac Catheterization and Rehabilitation in partnership with Prairie Heart Institute of Illinois, a Surgery Center, Women & Childrens Services, a Level II Perinatal Unit, Medical-Surgical units, Behavioral Health Services, Close Observation Unit, a Sleep Disorders Center, Diagnostic Imaging Services, and Laboratory. Outreach services include a durable medical company (Lincolnland Home Medical Equipment), a Reference Laboratory, Peace Meal, Lincolnland Home Health and Hospice, Lifeline, and Lincolnland Homemakers. Sarah Bush Lincoln has 14 extended campus primary care locations and three walk-in clinics. Employing about 2,350 area residents, the Health Center promotes a culture of excellence through continuing personal and professional growth.
Interim Healthcare of Greenville is a Greenville, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Liberty HomeCare and Hospice Services is a Wilmington, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
More than 20,000 genes make us human. Genes control critical aspects of health and disease — but what controls our genes? Foghorn® Therapeutics ($FHTX) is developing therapies based on a system that directs which genes our cells express, and when, where, and in what order. By manipulating this system with our unique Gene Traffic Control™ platform, Foghorn will change how genes turn “on” and “off.” Unlike approaches that edit genes, this novel way of thinking will alter what our DNA has in store for us—and rewrite destiny for millions of people living with disease. With Gene Traffic Control™ Foghorn is pioneering a new, major class of drug targets to develop unprecedented therapies for cancer and other serious diseases. We have already validated multiple targets, are in the process of developing drug candidates in multiple types of cancer and are beginning to explore other diseases.